This webcast will help clinicians develop a refined understanding of residual CVD risk in hypercholesterolemic patients and allow them to adjust prescribing behavior to reduce risk as much as possible.

This webcast discusses economic issues related to TAVR and resultant implications for availability of TAVR in various settings.

This webcast discusses the expanding indications for use of TAVR in additional patient populations.

This webcast provides a general overview of the Heart Team, its structure and its function in supporting successful valve procedures.

This program features slides and a transcription of the speakers’ presentations from a live meeting held on October 30, 2017. Internationally renowned experts discuss the clinical issues and recent data regarding antiplatelet/anticoagulation in patients with coronary artery disease (CAD).